is victoza a glp-1 drug drugs may have beneficial effect across many types of cancer GLP-1 Drugs Could Double Risk
Description
Medicare coverage for the drugs would total about $35 billion from 2026 to 2034 , per a Congressional Budget Office (CBO) analysis in October 2024
:max_bytes(150000):strip_icc()/VWH-GettyImages-2177964629-9f7413a5ef1b43cc9ba7cbdc67275974.jpg)
Apart from the pancreas, GLP-1R is also widely distributed in various tissues of the body including the lungs, kidneys, central nervous system, cardiovascular system, gastrointestinal tract, and skin and vagus nerves ( Glucagon like peptide-1 receptor agonists (GLP-1RAs) are emerging glucose control drugs, which are widely used in the treatment of T2MD in recent years

sitagliptin OR: 2.7, p = 0.008) and thyroid cancer (exenatide OR: 4.73, p = 0.004) [161]

These agents can promote vascular function by vasodilation and improve endothelial function by enhancing nitric oxide production [3, 6, 7]
A 2025 review specifically recommended this combination for GLP-1 users

In brief, islets were individually picked to ensure consistency across chambers with respect to both number and size